Several factors contribute to the underrepresentation of these groups in cancer research. These include socioeconomic barriers, limited access to healthcare, lack of awareness, cultural differences, and historical mistrust of the healthcare system. Additionally, clinical trials often lack diversity, which can result in findings that are not generalizable to the broader population.
